Opiant Pharmaceuticals Q3 EPS $1.97 Beats $(0.09) Estimate, Sales $20.641M Up From $4.366M YoY

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $(0.09) by 2288.89 percent. This is a 715.63 percent increase over losses of $(0.32) per

Benzinga · 11/12/2019 21:20

Opiant Pharmaceuticals (NASDAQ:OPNT) reported quarterly earnings of $1.97 per share which beat the analyst consensus estimate of $(0.09) by 2288.89 percent. This is a 715.63 percent increase over losses of $(0.32) per share from the same period last year. The company reported $20.641 million in sales this quarter. This is a 372.77 percent increase over sales of $4.366 million the same period last year.